ACTEMRA 200MG INJECTION contains Tocilizumab which belongs to the group of medicines called interleukin-6 (IL-6) receptor inhibitors. It is used to treat adults with moderate to severely active rheumatoid arthritis (an inflammatory disease affecting the joints).
It is also used in children aged 2 years and above to treat active systemic juvenile idiopathic arthritis and polyarticular juvenile idiopathic arthritis (inflammatory disease that causes pain and swelling in one or more joints).
ACTEMRA 200MG INJECTION is also used to treat adults and children aged 2 years and over with severe cytokine release syndrome (a side-effect in patients treated with chimeric antigen receptor (CAR) T-cell therapies used to treat certain types of cancer) and to treat adults with coronavirus disease 2019 (COVID-19), receiving systemic corticosteroids and requiring supplemental oxygen or mechanical ventilation.
ACTEMRA 200MG INJECTION is not recommended in patients with active, severe infection, active liver disease or liver impairment. It should be used with caution in patients with tuberculosis, mild to moderate kidney disease, intestinal ulcers or diverticulitis, cancer. Consult your doctor before receiving it.
ACTEMRA 200MG INJECTION is not recommended for use in pregnant women, breastfeeding mothers and in children under 2 years of age. Consult your doctor before receiving it.
The most common side effects of receiving ACTEMRA 200MG INJECTION include upper respiratory tract infections with typical symptoms such as cough, blocked nose, runny nose, sore throat and headache. Contact your doctor if any of the symptoms worsen.
To treat:
ACTEMRA 200MG INJECTION works by blocking the activity of a specific protein (cytokine) called interleukin 6, which is involved in inflammatory processes of the body and blocking it can reduce the pain and swelling in your joints.
ACTEMRA 200MG INJECTION will be given to you only by a doctor or a nurse as an injection into a vein as intravenous infusion. Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition. Do not stop using this medicine unless your doctor tells you to do so.
Stop receiving ACTEMRA 200MG INJECTION and contact your doctor immediately if you experience any of the following side effects:
Nausea:
Try to receive this medicine with or just after a meal or a snack. Stick to simple meals. Avoid eating oily rich or spicy food. Contact your doctor if your nausea did not improve.
Stomach pain:
Try to have smaller meals but take them frequently. Keep a heating pad on your stomach. Do not self-treat and contact your doctor if your stomach pain did not improve.
Headache:
Rest and relax. Drink plenty of fluids such as water or ORS (Oral Rehydrating Solution) and apply a pain-relieving balm on the head if necessary. Contact your doctor if your headache did not improve.
Dizziness:
Try to rest and relax. Get enough sleep. Avoid driving or operating any machines while you are feeling dizzy. Contact your doctor if your dizziness did not improve.
Skin rash:
Avoid hot baths because hot water can irritate your skin further. Do not scratch the affected area. Use sunscreen and wear protective clothing while going outside. Use unscented moisturizers to soothe and hydrate the affected area. Contact your doctor if your rashes worsen.
Diarrhoea:
Drink lots of fluids, such as water or fruit juices to keep yourself hydrated. Do not take any medicine on your own for treating diarrhoea. Contact your doctor if your diarrhoea did not improve.
ACTEMRA 200MG INJECTION is not recommended for use in pregnant women unless clearly necessary. Women of childbearing potential must use effective contraception during and up to 3 months after treatment. Contact your doctor before receiving ACTEMRA 200MG INJECTION.
ACTEMRA 200MG INJECTION is not recommended for use in breastfeeding mothers as it is not known if it is excreted in the breastmilk. Leave a gap of at least 3 months after your last treatment before starting breast-feeding. Consult your doctor before receiving ACTEMRA 200MG INJECTION.
Do not drive or operate any machines if you feel dizzy after receiving ACTEMRA 200MG INJECTION.
ACTEMRA 200MG INJECTION should be used with caution in patients with mild to moderate kidney disease with no dose adjustment. There is no information available on the use of this medicine in severe kidney disease. Consult your doctor before receiving ACTEMRA 200MG INJECTION.
ACTEMRA 200MG INJECTION is not recommended in patients with active liver disease or liver impairment. Consult your doctor before receiving ACTEMRA 200MG INJECTION.
Do not receive ACTEMRA 200MG INJECTION if you are allergic to Tocilizumab or any of the other ingredients of this medicine.
Do not receive ACTEMRA 200MG INJECTION if you are allergic to Tocilizumab or any of the other ingredients of this medicine.
ACTEMRA 200MG INJECTION should be used with caution in patients with risk of heart disease (such as high blood pressure and high cholesterol level). Consult your doctor before receiving ACTEMRA 200MG INJECTION.
ACTEMRA 200MG INJECTION is not recommended for use if you:
Before receiving ACTEMRA 200MG INJECTION, inform your doctor if you:
Use in paediatrics:
ACTEMRA 200MG INJECTION is not recommended for use in children under 2 years of age. Consult your doctor before receiving ACTEMRA 200MG INJECTION.
Use in geriatrics:
ACTEMRA 200MG INJECTION should be used with caution in the elderly patients above 65 years of age. Consult your doctor before receiving ACTEMRA 200MG INJECTION.
A. Drug-Drug interactions:
Before receiving ACTEMRA 200MG INJECTION, inform your doctor if you are taking any of the following medicines:
Overdosage:
ACTEMRA 200MG INJECTION will be given to you only by a doctor or nurse in a hospital and so it is unlikely to receive an overdose. However, if you experience any unusual symptoms, contact your doctor immediately.
Drug | : | Tocilizumab |
Pharmacological Category | : | Interleukin-6 (IL-6) receptor inhibitors |
Therapeutic Indication | : | Rheumatoid arthritis, Systemic juvenile idiopathic arthritis, Polyarticular juvenile idiopathic arthritis, Cytokine release syndrome, Coronavirus disease 2019 (COVID-19) |
Dosage Forms | : | Injection |
How often do you take ACTEMRA 200MG INJECTION?
ACTEMRA 200MG INJECTION will be given to you or to your child as an injection into a vein as an intravenous infusion once every 2 weeks or 4 weeks. Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition.
Does ACTEMRA 200MG INJECTION cause dizziness?
Yes, ACTEMRA 200MG INJECTION may cause dizziness. Try to rest and relax. Get enough sleep. Avoid driving or operating any machines while you are feeling dizzy. Contact your doctor if your dizziness did not improve.
Is ACTEMRA 200MG INJECTION safe for use in pregnant women?
ACTEMRA 200MG INJECTION is not recommended for use in pregnant women unless clearly necessary. Women of childbearing potential must use effective contraception during and up to 3 months after treatment. Contact your doctor before receiving ACTEMRA 200MG INJECTION.
Who should not receive ACTEMRA 200MG INJECTION?
ACTEMRA 200MG INJECTION is not recommended for use in pregnant, breastfeeding mothers with, allergic history to tocilizumab, active, severe infection, active liver disease or liver impairment and in children under 2 years of age. Consult your doctor before receiving ACTEMRA 200MG INJECTION.
What happens when you forget to receive ACTEMRA 200MG INJECTION?
ACTEMRA 200MG INJECTION will be given to you by a doctor or a nurse. It’s unlikely for you to miss the dose. However, if you are worried, talk to your doctor or nurse.
Is ACTEMRA 200MG INJECTION safe for use in children?
ACTEMRA 200MG INJECTION should be used with caution for the treatment of polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, cytokine release syndrome in children aged 2 years and above. Consult your doctor before receiving ACTEMRA 200MG INJECTION.
1. Bertram G. Katzung. NSAIDs, Antirheumatic Drugs, Nonopioid Analgesics, & Drugs used in Gout. Basic and Clinical Pharmacology. 14th edition. 2018. Page – 653.
2. Graeme Jones and Changhai Ding. Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis. NIH National Library of Medicine, National Center for Biotechnology Information. PubMed Central. December 2010. [Accessed on 22nd June 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018893/
3. Charles V. Preuss, Fatima Anjum. Tocilizumab. NIH National Library of Medicine, National Center for Biotechnology Information. StatPearls. [Revised in March 2022] [Accessed on 22nd June 2022] https://www.ncbi.nlm.nih.gov/books/NBK570644/
4. Roche Products Ltd. Electronic Medicines Compendium (EMC). Tocilizumab [Revised in January 2022] [Accessed on 22nd June 2022] https://www.medicines.org.uk/emc/files/pil.6673.pdf
5. Tocilizumab Injection. DailyMed: National Library of Medicine: National Institute of Health. [Revised in June 2022] [Accessed on 22nd June 2022] https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13&type=display#section-7
6. Actemra IV Injection (Tocilizumab). Ciplamed. [Revised in February 2021] [Accessed on 22nd June 2022] https://ciplamed.com/content/actemra-iv-injection
Written By Dr. N. Sai Swaroop, Pharm.D
Last updated on 11 Jan 2023 | 06:02 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.